tradingkey.logo
tradingkey.logo
Suchen

Mangoceuticals Inc

MGRX
Zur Watchlist hinzufügen
0.370USD
0.0000.00%
Handelsschluss 06/30, 16:00ETKurse um 15 Minuten verzögert
6.28MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Mangoceuticals Inc Unternehmen

Mangoceuticals, Inc. is focused on developing men’s and women’s health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.

Mangoceuticals Inc Informationen

BörsenkürzelMGRX
Name des UnternehmensMangoceuticals Inc
IPO-datumMar 21, 2023
CEOCohen (Jacob D)
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeMar 21
Addresse15110 Dallas Pkwy, Suite 600
StadtDALLAS
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl75248
Telefon18336264679
Websitehttps://www.mangorx.com/
BörsenkürzelMGRX
IPO-datumMar 21, 2023
CEOCohen (Jacob D)

Führungskräfte von Mangoceuticals Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Kenny Myers
Dr. Kenny Myers
Independent Non-Executive Director
Independent Non-Executive Director
136.67K
--
Mr. Eugene M. Johnston
Mr. Eugene M. Johnston
Chief Financial Officer
Chief Financial Officer
120.00K
--
Mr. Alex P. Hamilton
Mr. Alex P. Hamilton
Independent Non-Executive Director
Independent Non-Executive Director
3.33K
+49.01%
Mr. Jacob D. Cohen
Mr. Jacob D. Cohen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lorraine Dalessio, Esq.
Ms. Lorraine Dalessio, Esq.
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Kenny Myers
Dr. Kenny Myers
Independent Non-Executive Director
Independent Non-Executive Director
136.67K
--
Mr. Eugene M. Johnston
Mr. Eugene M. Johnston
Chief Financial Officer
Chief Financial Officer
120.00K
--
Mr. Alex P. Hamilton
Mr. Alex P. Hamilton
Independent Non-Executive Director
Independent Non-Executive Director
3.33K
+49.01%
Mr. Jacob D. Cohen
Mr. Jacob D. Cohen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lorraine Dalessio, Esq.
Ms. Lorraine Dalessio, Esq.
Independent Non-Executive Director
Independent Non-Executive Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Mangoceuticals Inc?

Die fünf größten Anteilseigner von Mangoceuticals Inc sind: Dr. Kenny Myers

Wie viele Institutionen halten Anteile an Mangoceuticals Inc (MGRX)?

Mit Stand vom 2026Q1 halten 37 Institutionen Anteile an Mangoceuticals Inc, mit einem Gesamtmarktwert von etwa 2.67M, was 15.75% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 2145026.00 gestiegen.